Molecular and Contextual Markers of Hepatitis C Virus and Drug Abuse

被引:0
|
作者
Paul Shapshak
Charurut Somboonwit
Lydia N. Drumright
Simon D.W. Frost
Deborah Commins
Timothy L. Tellinghuisen
William K. Scott
Robert Duncan
Clyde McCoy
J. Bryan Page
Brian Giunta
Francisco Fernandez
Elyse Singer
Andrew Levine
Alireza Minagar
Oluwadayo Oluwadara
Taiwo Kotila
Francesco Chiappelli
John T. Sinnott
机构
[1] University of South Florida Health,Division of Infectious Disease and International Medicine, Department of Internal Medicine
[2] College of Medicine,Department of Psychiatry and Behavioral Medicine
[3] University of South Florida,Hillsborough Health Department
[4] College of Medicine,Division of International Health, Department of Medicine
[5] Clinical Research Unit,Department of Veterinary Medicine
[6] University of California,Department of Pathology
[7] University of Cambridge,Miami Institute for Human Genomics
[8] University of Southern California Keck School of Medicine,Department of Epidemiology, Comprehensive Drug Research Center
[9] Scripps Research Institute,Department of Anthropology, University of Miami, Coral Gables, and Department of Psychiatry and Behavioral Sciences, Comprehensive Drug Research Center
[10] University of Miami Miller School of Medicine,Department of Neurology and National Neurological AIDS Bank
[11] University of Miami Miller School of Medicine,Department of Neurology
[12] University of Miami Miller School of Medicine,Division of Oral Biology and Medicine
[13] UCLA School of Medicine,Department of Anatomy, College of Medicine
[14] Louisiana State University Health Sciences Center,Department of Hematology
[15] UCLA School of Dentistry,undefined
[16] University of Ibadan,undefined
[17] College of Medicine and University College Hospital,undefined
[18] University of Ibadan,undefined
来源
关键词
Treg Cell; Injection Drug Abuse;
D O I
暂无
中图分类号
学科分类号
摘要
The spread of hepatitis C virus (HCV) infection involves a complex interplay of social risks, and molecular factors of both virus and host. Injection drug abuse is the most powerful risk factor for HCV infection, followed by sexual transmission and additional non-injection drug abuse factors such as co-infection with other viruses and barriers to treatment. It is clearly important to understand the wider context in which the factors related to HCV infection occur. This understanding is required for a comprehensive approach leading to the successful prevention, diagnosis, and treatment of HCV. An additional consideration is that current treatments and advanced molecular methods are generally unavailable to socially disadvantaged patients. Thus, the recognition of behavioral/social, viral, and host factors as components of an integrated approach to HCV is important to help this vulnerable group. Equally important, this approach is key to the development of personalized patient treatment — a significant goal in global healthcare.
引用
收藏
页码:153 / 179
页数:26
相关论文
共 50 条
  • [1] Molecular and Contextual Markers of Hepatitis C Virus and Drug Abuse
    Shapshak, Paul
    Somboonwit, Charurut
    Drumright, Lydia N.
    Frost, Simon D. W.
    Commins, Deborah
    Tellinghuisen, Timothy L.
    Scott, William K.
    Duncan, Robert
    McCoy, Clyde
    Page, J. Bryan
    Giunta, Brian
    Fernandez, Francisco
    Singer, Elyse
    Levine, Andrew
    Minagar, Alireza
    Oluwadara, Oluwadayo
    Kotila, Taiwo
    Chiappelli, Francesco
    Sinnott, John T.
    MOLECULAR DIAGNOSIS & THERAPY, 2009, 13 (03) : 153 - 179
  • [2] Drug abuse, innate immunity and hepatitis C virus
    Zhang, Ting
    Li, Yuan
    Ho, Wen-Zhe
    REVIEWS IN MEDICAL VIROLOGY, 2006, 16 (05) : 311 - 327
  • [3] Molecular markers of hepatitis C virus-related hepatocellular carcinoma
    Sultan, Ahmed S.
    El Gendy, S.
    Hessien, Mohamed
    El Sherbiny, Mahmoud
    Ibrahim, Abdel Selam M.
    Sherif, Zaki A.
    CANCER BIOLOGY & THERAPY, 2006, 5 (06) : 623 - 629
  • [4] Molecular biology of liver disorders:the hepatitis C virus and molecular targets for drug development
    Howard J. Worman
    World Journal of Gastroenterology, 2000, 6 (04) : 465 - 469
  • [5] Molecular biology of liver disorders: the hepatitis C virus and molecular targets for drug development
    Worman, HJ
    Lin, F
    WORLD JOURNAL OF GASTROENTEROLOGY, 2000, 6 (04) : 465 - 469
  • [6] Primary hepatitis C virus infection in an intravenous drug user: kinetics of virological markers
    Zachary, Pierre
    Wendling, Marie-Josee
    Djeddi, Saadi
    Schvoerer, Evelyne
    Ullmann, Murielle
    Stoll-Keller, Francoise
    Gut, Jean-Pierre
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2006, 30 (12): : 1419 - 1420
  • [7] Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan
    Satoh, Y
    Hino, K
    Kato, T
    Mizokami, M
    Yamashita, S
    Nakamura, H
    Okita, K
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (11) : 1305 - 1311
  • [8] Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals
    Coppola, Nicola
    Pisaturo, Mariantonietta
    Zampino, Rosa
    Macera, Margherita
    Sagnelli, Caterina
    Sagnelli, Evangelista
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (38) : 10749 - 10759
  • [9] Hepatitis c virus markers in infection by hepatitis c virus: In the era of directly acting antivirals
    Nicola Coppola
    Mariantonietta Pisaturo
    Rosa Zampino
    Margherita Macera
    Caterina Sagnelli
    Evangelista Sagnelli
    World Journal of Gastroenterology, 2015, 21 (38) : 10749 - 10759
  • [10] Non-transfusional and non-intravenous drug abuse transmission of hepatitis C virus
    Serfaty, L
    PRESSE MEDICALE, 1999, 28 (21): : 1135 - 1140